Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

No increase in Covid deaths amid surge in cases: DOH

Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

The mortality curve of reported deaths nationwide due to the coronavirus disease 2019 (Covid-19) continues to go down, a health expert said yesterday.

“This month of March, we haven’t seen an increase in deaths, we have deaths [average of 10 per day], that is one of the lowest since the start of the pandemic,” said Dr. Alethea de Guzman, Department of Health Epidemiology Bureau director during an online media forum.

Based on the latest DOH data, the highest average death per day due to Covid-19 is 67 which happened last August 2020.

“But we’re monitoring this because we see in our mortality curve when [cases] peak by the first week of August, the deaths peak) either that same week or the following week,” de Guzman said.

Part of the government’s pandemic response efforts is to prevent deaths due to Covid-19.

It monitors the healthcare utilization rate (HCUR) of hospital beds — intensive care unit beds, isolation beds, and ward beds — reserved for moderate, severe, and critical cases.

“Regionally, all are in safe zone, no region has reached 60 percent, we also see while they are all in the safe zone there is an increase in the healthcare utilization rate,” de Guzman said.

She noted the National Capital Region’s HCUR increased by 21 percent in a week while Calabarzon increased by 19 percent.

“So, this is aligned, consistent with the increase of cases in these places. We’re monitoring each region, their increase in HCUR or ICU rate, we study how to lower it,” she said.

De Guzman also stressed the importance of triage in hospitals and the referral of patients who are either asymptomatic or with mild Covid-19 symptoms to community quarantine facilities.*PNA

ARCHIVES

Read Article by date

April 2024
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 

Get your copy of the Visayan Daily Star everyday!

Avail of the FREE 30-day trial.